Loading...
Agio Pharmaceuticals Limited — Miconazole Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #8 for Miconazole · $389.8K export value · DGFT Verified
Agio Pharmaceuticals Limited is the #8 Indian exporter of Miconazole with $389.8K in export value and 26 verified shipments. Agio Pharmaceuticals Limited holds a 2.0% market share in Miconazole exports across 2 countries. The company exports 15 pharmaceutical products worth $11.9M across 8 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| RUSSIA | $221.0K | 11 | 56.9% |
| SRI LANKA | $167.1K | 15 | 43.1% |
Agio Pharmaceuticals Limited exports Miconazole to 2 countries. The largest destination is RUSSIA accounting for 56.9% of Agio Pharmaceuticals Limited's Miconazole shipments. These destinations reflect Agio Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AGIO RUS LLC | RUSSIA | $208.6K | 10 |
| TO THE ORDER OF PEOPLE S BANK | SRI LANKA | $46.1K | 1 |
| TO THE ORDER OF COMMERCIAL BANK OF | SRI LANKA | $37.0K | 3 |
| CITIHEALTH IMPORTS PVT LTD | SRI LANKA | $35.8K | 4 |
| TO THE ORDER OF HATTON | SRI LANKA | $25.5K | 2 |
| OOO E.T.C. PHARMA | RUSSIA | $12.4K | 1 |
| TO THE ORDER OF COMMERCIAL | SRI LANKA | $8.6K | 3 |
| CITIHEALTH IMPORTS PRIVATE LIMITED | SRI LANKA | $8.6K | 1 |
Agio Pharmaceuticals Limited supplies Miconazole to 9 buyers globally. The largest buyer is AGIO RUS LLC (RUSSIA), followed by TO THE ORDER OF PEOPLE S BANK (SRI LANKA) and TO THE ORDER OF COMMERCIAL BANK OF (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $13.3M worth of Miconazole through 3,584 shipments from 365 suppliers to 148 countries, serving 1,163 buyers globally. Agio Pharmaceuticals Limited contributes $389.8K to this total, accounting for 2.0% of India's Miconazole exports. Agio Pharmaceuticals Limited ships Miconazole to 2 countries through 9 buyers.
Agio Pharmaceuticals Limited's average Miconazole shipment value is $15.0K per consignment, based on 26 shipments totaling $389.8K. The largest destination is RUSSIA (56.9% of Agio Pharmaceuticals Limited's Miconazole exports).
Agio Pharmaceuticals Limited ranks #8 among 365 Indian Miconazole exporters with a 2.0% market share. The top 3 exporters are ENCUBE ETHICALS PRIVATE LIMITED ($5.6M), MEPRO PHARMACEUTICALS PRIVATE LIMITED ($1.5M), LEBEN LABORATORIES PRIVATE LIMITED ($1.1M). Agio Pharmaceuticals Limited processed 26 shipments to 2 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MICOSON 2% CREAM (MICONAZOLE NITRATE CREAM USP 2% W/W) | $229.8K | 13 |
| MICOSON 2% CREAM 15GM MICONAZOLE NITRAT | $46.1K | 1 |
| MICOSON 2% CREAM (MICONAZOLE CREAM USP 2 | $28.5K | 2 |
| MICONAZOLE NITRATE CREAM USP 2 W W MICONAZOLE NITRATE CREAM USP 2 W W | $27.2K | 1 |
| MICOSON 2% CREAM (MICONAZOLE NITRATE CRE | $22.6K | 3 |
| MICOSON 2% CREAMMICONAZOLE NITRATE CREAM USP 2%W/WBNO.E23298 MD.10/23 ED.09/26 | $11.3K | 1 |
| MICOSON 2% CREAM (MICONAZOLE NITRATE CREAM USP 2% W/W)NOS | $8.6K | 3 |
| MICOSON 2% CREAM MICONAZOLE NITRATE CRE | $8.6K | 1 |
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | BLUE CROSS LABORATORIES PRIVATE LIMITED | $910.1K | 30 | 8 | $30.3K |
| 7 | MULTICO EXPORTS PRIVATE LIMITED | $438.4K | 10 | 2 | $43.8K |
| 8 | AGIO PHARMACEUTICALS LIMITED ★ | $389.8K | 26 | 2 | $15.0K |
| 9 | GALENTIC PHARMA INDIA PVT LTD | $372.4K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 652 | 18.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 477 | 13.3% |
| NHAVA SHEVA SEA (INNSA1) | 407 | 11.4% |
| JNPT/ NHAVA SHEVA SEA | 261 | 7.3% |
| JNPT | 197 | 5.5% |
| DELHI AIR CARGO ACC (INDEL4) | 162 | 4.5% |
| Bombay Air | 146 | 4.1% |
| DELHI AIR | 128 | 3.6% |
Agio Pharmaceuticals Limited also exports these antifungals products. Each links to the detailed product page.
Recent geopolitical developments have introduced complexities into the pharmaceutical export landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential losses for Indian exporters. According to Pharmaceutical Commerce, maritime carriers' booking suspensions and diversions around the Cape of Good Hope are elongating lead times and pressurizing Suez-linked lanes, disproportionately impacting time-sensitive pharmaceutical replenishment cycles. This situation poses challenges for Agio Pharmaceuticals, particularly in maintaining timely deliveries to key markets.
In the United States, recent tariff implementations have affected a significant portion of Indian exports. The Federation of Indian Export Organisations highlighted that the latest U.S. tariffs impact nearly 55% of India's outbound shipments to America, placing Indian exporters at a competitive disadvantage. For Agio, which relies on the U.S. market, these tariffs could necessitate strategic adjustments to pricing and supply chain logistics.
The European Union's stringent regulatory changes, including the Falsified Medicines Directive, demand enhanced compliance measures from exporters. Agio's ability to adapt to these evolving standards will be crucial in sustaining its market presence in the EU.
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA increasing inspections of manufacturing facilities. India, hosting over 600 US FDA-approved sites, faces challenges in maintaining compliance. The US FDA conducted more than 200 inspections in 2023, with plans to increase this number in 2024. For Agio Pharmaceuticals, ensuring adherence to Good Manufacturing Practices (GMP) and other quality standards is imperative to avoid potential export bans or reputational damage.
Additionally, the prevalence of counterfeit drugs has raised concerns about India's reputation as a reliable supplier. Agio must implement robust quality control systems and transparent governance to navigate this landscape effectively.
Agio Pharmaceuticals Limited exports 15 products worth $11.9M. Beyond Miconazole, top products include Dexamethasone, Phenylephrine, Clotrimazole, Prednisolone, Salbutamol. View the complete Agio Pharmaceuticals Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Miconazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Agio Pharmaceuticals Limited's Miconazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Agio Pharmaceuticals Limited
Full Company Profile →
15 products · $11.9M total trade · 8 categories
| TO THE ORDER OF MASHREQ BANK PSC | SRI LANKA | $5.6K | 1 |
| MICOSON 2 CREAM MICONAZOLE NITRATE CREAM USP 2 W W |
| $5.6K |
| 1 |
Agio Pharmaceuticals Limited exports 9 distinct Miconazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MICOSON 2% CREAM (MICONAZOLE NITRATE CREAM USP 2% W/W) with 13 shipments worth $229.8K.
| 26 |
| 4 |
| $14.3K |
| 10 | CIPLA LIMITED | $362.5K | 48 | 4 | $7.6K |
Agio Pharmaceuticals Limited ranks #8 among 365 Indian Miconazole exporters. Average shipment value of $15.0K compared to the market average of $36.5K. The closest competitors by value are BLUE CROSS LABORATORIES PRIVATE LIMITED and MULTICO EXPORTS PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 148+ countries, 1,163+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Agio Pharmaceuticals Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Miconazole. For current shipment-level data, contact TransData Nexus.